John Tsai is on the board of Blueprint Medicines Corp. In the past he occupied the position of Chief Medical Officer & SVP-Global Medical at Amgen, Inc., Chief Medical Officer of Novartis AG and Head-Clinical Development at Bristol Myers Squibb Co.

He received a doctorate from the University of Louisville School of Medicine and an undergraduate degree from Washington University in St. Louis.